Quick Answer
American Well Corp reported Research And Development Expense of $72.86 million for the year ending 2025.
- American Well Corp showed a decrease of -15.3% in Research And Development Expense from 2024 to 2025.
- This data is from American Well Corp's annual report (Form 10-K), filed with the SEC on February 12, 2026.
- XBRL data for this metric is available from 2018 to 2025 (8 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2019: $13.60 million | Q1 2020: $14.94 million | Q2 2020: $17.64 million | Q3 2020: $25.28 million | Q1 2021: $23.04 million | Q2 2021: $22.38 million | Q3 2021: $27.40 million | Q1 2022: $37.48 million | Q2 2022: $37.07 million | Q3 2022: $36.25 million | Q1 2023: $25.92 million | Q2 2023: $25.84 million | Q3 2023: $27.72 million | Q1 2024: $26.68 million | Q2 2024: $20.81 million | Q3 2024: $19.80 million | Q1 2025: $22.10 million | Q2 2025: $18.24 million | Q3 2025: $18.58 million.
- Over the full 8 years of available data (2018 to 2025), American Well Corp's Research And Development Expense has grown by 100.9%.
- Historical annual values: Fiscal year 2025: $72.86 million | Fiscal year 2024: $86.07 million | Fiscal year 2023: $105.83 million | Fiscal year 2022: $138.49 million | Fiscal year 2021: $106.59 million | Fiscal year 2020: $84.41 million | Fiscal year 2019: $53.94 million | Fiscal year 2018: $36.27 million.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: